Microbix Biosystems Inc. (TSE:MBX) Director Sells C$86,500.00 in Stock

Microbix Biosystems Inc. (TSE:MBX) Director Cameron Lionel Groome sold 200,000 shares of Microbix Biosystems stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of C$0.43, for a total transaction of C$86,500.00.

Microbix Biosystems Price Performance

MBX opened at C$0.49 on Friday. The company has a debt-to-equity ratio of 22.68, a current ratio of 6.62 and a quick ratio of 5.57. The company has a market capitalization of C$66.98 million, a price-to-earnings ratio of 12.25 and a beta of 0.34. The firm’s fifty day moving average price is C$0.38 and its two-hundred day moving average price is C$0.35. Microbix Biosystems Inc. has a 1 year low of C$0.29 and a 1 year high of C$0.52.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.